RSSS

+ Watchlist + Portfolio

Research Solutions, Inc

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.21
52-Week Range: $2.00 – $4.12
Market Cap: $73.58M
P/E (TTM): 14.67
EPS (TTM): 0.15
Dividend Yield: —

Advanced Metrics

Price/Book: 3.70
PEG Ratio: 1.38
Return on Equity: 29.82%
Return on Assets: 5.42%
Gross Margin: 51.39%
Operating Margin: 8.62%
Profit Margin: 9.28%
Current Ratio: 0.82
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $4.57M
Revenue Growth: -4.30%
Earnings Growth: 285.40%
Enterprise Value: $59.22M

RSSS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$32.93M	$37.70M	$44.62M	$49.06M
Cost of Revenue	$20.91M	$23.00M	$24.98M	$24.86M
Gross Profit	$12.02M	$14.70M	$19.64M	$24.20M
Research & Development	$3.71M	$3.74M	$5.44M	$5.63M
Selling, General & Admin	$9.78M	$10.79M	$14.11M	$15.02M
Operating Expenses	$13.51M	$14.58M	$20.39M	$21.90M
Operating Income	-$1.49M	$116.66K	-$748.15K	$2.30M
EBITDA	-$1.47M	$169.30K	$88.12K	$3.54M
Pretax Income	-$1.62M	$577.23K	-$3.67M	$1.35M
Income Tax	$7.62K	$5.60K	$113.07K	$82.81K
Net Income	-$1.63M	$571.62K	-$3.79M	$1.27M
Diluted EPS	-0.06	0.02	-0.13	0.04
Diluted Shares	26.42M	29.14M	28.86M	31.50M

RSSS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$10.60M	$13.55M	$6.10M	$12.23M
Receivables	$5.25M	$6.15M	$6.88M	$7.19M
Current Assets	$16.98M	$21.30M	$14.69M	$20.00M
Total Assets	$17.03M	$21.83M	$41.86M	$46.12M
Current Liabilities	$12.14M	$14.50M	$17.87M	$25.51M
Total Liabilities	$12.14M	$14.50M	$30.17M	$32.19M
Retained Earnings	-$23.09M	-$22.52M	-$26.31M	-$25.04M
Shareholders' Equity	$4.88M	$7.33M	$11.69M	$13.93M
Working Capital	$4.83M	$6.80M	-$3.18M	-$5.51M

RSSS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$417.20K	$3.38M	$3.55M	$7.02M
Capital Expenditure	-$44.29K	-$47.21K	-$71.51K	-$19.26K
Free Cash Flow	-$461.49K	$3.34M	$3.48M	$7.00M
Depreciation & Amortisation	$17.65K	$52.65K	$836.27K	$1.25M
Investing Cash Flow	-$44.29K	-$344.66K	-$10.10M	-$19.26K
Financing Cash Flow	$63.27K	-$97.26K	-$905.85K	-$877.88K
Share Repurchases	-$93.92K	-$104.25K	-$554.20K	-$934.58K
Net Change in Cash	-$398.22K	$2.94M	-$7.45M	$6.13M

RSSS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$12.66M	$12.44M	$12.31M	$11.79M	$12.12M
Cost of Revenue	$6.39M	$6.10M	$6.09M	$5.62M	$5.86M
Gross Profit	$6.27M	$6.34M	$6.23M	$6.18M	$6.27M
Research & Development	$1.39M	$1.36M	$1.41M	$1.60M	$1.51M
Selling, General & Admin	$4.05M	$3.55M	$3.55M	$3.48M	$3.38M
Operating Expenses	$5.75M	$5.22M	$5.28M	$5.40M	$5.21M
Operating Income	$512.40K	$1.12M	$944.41K	$775.46K	$1.06M
EBITDA	$541.89K	$1.44M	$1.26M	$1.09M	$1.44M
Pretax Income	$229.88K	$2.37M	$770.62K	$555.78K	$882.37K
Income Tax	$13.41K	$8.00K	$21.23K	$8.86K	$22.17K
Net Income	$216.47K	$2.36M	$749.39K	$546.92K	$860.21K
Diluted EPS	0.01	—	0.02	0.02	0.03
Diluted Shares	32.14M	—	32.07M	32.33M	32.44M

RSSS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$9.85M	$12.23M	$11.96M	$12.26M	$12.05M
Receivables	$7.60M	$7.19M	$6.90M	$5.66M	$7.60M
Current Assets	$18.84M	$20.00M	$19.66M	$18.67M	$20.68M
Total Assets	$45.23M	$46.12M	$45.51M	$44.24M	$45.95M
Current Liabilities	$24.90M	$25.51M	$24.88M	$23.61M	$25.10M
Total Liabilities	$34.00M	$32.19M	$29.92M	$27.02M	$26.89M
Retained Earnings	-$27.40M	-$25.04M	-$24.29M	-$23.75M	-$22.89M
Shareholders' Equity	$11.23M	$13.93M	$15.59M	$17.23M	$19.06M
Working Capital	-$6.07M	-$5.51M	-$5.22M	-$4.94M	-$4.43M

RSSS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$2.89M	$2.26M	$1.11M	$1.38M	$1.01M
Capital Expenditure	-$6.17K	-$7.69K	-$17.54K	-$7.02K	-$4.05K
Free Cash Flow	$2.89M	$2.25M	$1.09M	$1.38M	$1.00M
Depreciation & Amortisation	$312.01K	$315.02K	$316.07K	$316.43K	$312.40K
Investing Cash Flow	-$6.17K	-$7.69K	-$17.54K	-$7.02K	-$4.05K
Financing Cash Flow	-$731.73K	$121.68K	-$1.36M	-$1.08M	-$1.22M
Share Repurchases	-$703.12K	-$26.18K	-$23.39K	-$16.16K	-$7.84K
Net Change in Cash	$2.15M	$2.37M	-$271.66K	$301.84K	-$215.78K

Market Snapshot

About

Research Solutions, Inc. provides cloud-based research intelligence solutions for life science and healthcare professionals. The company offers services that streamline the acquisition, management, and sharing of scientific content and data. Research Solutions serves pharmaceutical companies, biotech firms, academic institutions, and corporate research organizations.